Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208793 · ClinicalTrials.gov registry record · Phase 2
Calcium and Vitamin D vs Markers of Adenomatous Polyps
A Phase 2 study of Colorectal Adenomatous Polyps, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT00208793 is a Phase 2 study of Colorectal Adenomatous Polyps that has completed, run by Emory University. The registered enrollment target is 92 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00208793, a Phase 2 study of Colorectal Adenomatous Polyps, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test whether calcium and/or vitamin D supplementation favorably affects a set of biomarkers of risk for colon cancer in persons who are at higher than average risk for colon cancer (ie, have already undergone the removal of adenomatous polyps, which are known to be precursors to developing colon cancer).
Conditions Studied
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Calcium and vitamin D3 combined
- DIETARY_SUPPLEMENT Calcium
Study Locations (1)
Georgia
- The Emory Clinic, Division of Digestive Diseases - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2005-05 |
| Est. Completion | 2013-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208793
The ClinicalTrials.gov registry entry for NCT00208793 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Adenomatous Polyps appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT00208793 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00208793 about?
NCT00208793 is a clinical study titled "Calcium and Vitamin D vs Markers of Adenomatous Polyps". The purpose of this study is to test whether calcium and/or vitamin D supplementation favorably affects a set of biomarkers of risk for colon cancer in persons who are at higher than average risk for colon cancer (ie, have already undergone the removal of adenomatous polyps, which are known to be pr...
What is the current status of trial NCT00208793?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2005-05. Estimated completion is 2013-02.
What conditions does trial NCT00208793 study?
This clinical trial studies the following conditions: Colorectal Adenomatous Polyps.
What interventions are being tested in trial NCT00208793?
The interventions under investigation include: Placebo (DRUG), Vitamin D3 (DIETARY_SUPPLEMENT), Calcium and vitamin D3 combined (DIETARY_SUPPLEMENT), Calcium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00208793?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00208793 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Adenomatous Polyps
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.